Taylor Hooton Foundation > Hoot’s Corner > Podcasts > Episode 134: Weight Loss, Wellness, and the Truth About GLP-1 – Dr. Maureen Gibbons
November 3, 2025
Episode 134: Weight Loss, Wellness, and the Truth About GLP-1 – Dr. Maureen Gibbons


The ALL ME® Podcast

Weight Loss, Wellness, and the Truth About GLP-1 – Dr. Maureen Gibbons

In this episode of the ALL ME Podcast, host Brian Parker discusses GLP-1 (glucagon-like peptide 1) with Dr. Maureen Gibbons, who shares her expertise on the topic. They explore the medical implications of GLP-1, its role in diabetes and weight loss, and the various FDA-approved drugs in this class.

Dr. Gibbons emphasizes the importance of understanding the natural production of GLP-1 in the body and discusses the safety and side effects of these medications. The conversation also touches on who should avoid GLP-1 drugs and the broader implications for health and wellness.

In this conversation, Dr. Moe discusses the long-term safety of medications for weight loss, particularly focusing on GLP-1 receptor agonists. She shares her personal experience with weight loss and the mental health benefits of these medications.

The discussion also touches on the cultural shift towards using medication for cosmetic weight loss, the dangers of the gray market for medications, and the importance of seeking professional help rather than relying on unregulated sources. Dr. Moe emphasizes the need for a supportive community and the role of coaching in achieving sustainable health outcomes.

Takeaways

  • GLP-1 is crucial for understanding modern weight loss drugs.
  • Dr. Maureen Gibbons has extensive experience in lifestyle medicine.
  • The half-life of GLP-1 drugs varies significantly.
  • There are multiple FDA-approved GLP-1 medications available.
  • GLP-1 drugs can help with both diabetes and weight loss.
  • Natural production of GLP-1 can be enhanced through diet and exercise.
  • Safety profiles of GLP-1 drugs are generally favorable.
  • Every medication comes with risks that need to be considered.
  • Certain populations should avoid GLP-1 medications.
  • Behavioral change is essential for effective health management. Long-term safety of medications is a personal decision.
  • Weight loss medications can provide mental health benefits.
  • Cultural shifts towards medication for weight loss raise concerns.
  • The gray market for medications poses significant risks.
  • Seeking professional help is crucial for safe treatment.
  • Behavioral changes are essential for sustainable weight loss.
  • Coaching can help navigate the complexities of health care.
  • Insurance coverage for medications is inconsistent and complex.
  • The cost of medications is gradually decreasing.
  • Community support is vital for individuals seeking help.

 

Chapters

00:00  Introduction to GLP-1 and Its Importance

02:32  Dr. Maureen Gibbons: Background and Expertise

06:52  Understanding GLP-1: Medical Insights

10:09  The Functionality of GLP-1 Drugs

12:17  Exploring FDA Approved GLP-1 Drugs

14:24  The Role of GLP-1 in Weight Loss and Diabetes

17:23  Natural Ways to Boost GLP-1 Production

20:48  Safety and Side Effects of GLP-1 Drugs

26:30  Who Should Avoid GLP-1 Medications?

29:04  Long-Term Safety of Medications

35:58  The Role of Medication in Weight Loss

43:01  Navigating the Gray Market for Medications

50:06  Final Thoughts on Seeking Help

 

Follow Us:

  • Twitter: @theTHF
  • Instagram: @theTHF
  • Facebook: Taylor Hooton Foundation
  • #ALLMEPEDFREE

Contact Us: 


Check out this episode!